Original Query: ALL
Previous Study | Return to List | Next Study

Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous Insulin Infusion (CSII) Type 2 Treated Patients With Type 2 Diabetes (EXEPUMP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01140893
Recruitment Status : Recruiting
First Posted : June 10, 2010
Last Update Posted : August 23, 2016
Eli Lilly and Company
Information provided by (Responsible Party):
University Hospital, Caen

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : May 2017
  Study Completion Date : No date given